Ann Arbor
Michigan, 48105
Available to mentor
Dr. Kraftson specializes in treating patients with excess weight/ obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the director of the Weight Navigation Program, director of the Post-Bariatric Endocrinology Clinic, and a participating physician in the Weight Management Program. His research focuses on understanding current treatment practices for patients with excess weight and obesity and seeking to improve and personalize that care. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the MEND Endocrinology Fellowship.
-
Center MemberCaswell Diabetes Institute
-
Amenabar T, Gilbert D. 2024 Jul 18;Additional ScholarshipWashington Post Interview: What to know about cheaper, imitation weight-loss drugs
-
Kraftson A, Griauzde D. JAMA Intern Med, 2024 Jul 1; 184 (7): 854Journal ArticleWhat Should I Know About Injectable Weight-Loss Medications?
DOI:10.1001/jamainternmed.2023.7268 PMID: 38466303 -
Blum D. 2024 May 13;Additional ScholarshipNew York Times Interview: How Ozempic is Changing Diabetes Treatment
-
Myerson M. 2024 May 3;Additional ScholarshipMedical Economics Interview: The new weight loss drugs
-
Griauzde DH, Turner CD, Othman A, Oshman L, Gabison J, Arizaca-Dileo PK, Walford E, Henderson J, Beckius D, Lee J, Carter E, Dallas C, Herrera-Theut1 K, Richardson CR, Kullgren J, Piatt G, Heisler M, Kraftson A. JAMA Network Open, 2024 May; 7 (5): e2412192 - e2412192.Journal ArticleEvaluation of a Primary Care-based Weight Navigation Program: a Matched Cohort Analysis
-
Blum D. 2024 Mar 11;Additional ScholarshipNew York Times Interview: Wegovy Moves Beyond Weight Loss
-
Kraftson A. 2024 Feb 28;PresentationSleep Medicine Grand Rounds: Obesity Treatment Updates
-
Kraftson A. 2024 Feb 27;PresentationVillanova University: Obesity Treatment Teams in the Age of Weight Control Medications